The differences between the various Zoll electrode pads

These pads are suitable for the Zoll AED Plus and the Zoll AED Pro. Which ones should you choose?  In the overview below we have set out the differences that may help to make your choice easier.

Click here to view the Zoll electrode pads in our web shop.
 As you can see there are 4 types. All of these electrode pads can be used with the Zoll AED Plus and the Zoll AED Pro and are interchangeable with the professional monitors/ defibrillators from Zoll that are used by ambulance services. All these sets can be used once only. After they have been removed from their sealed package they must be used straightaway.  Electrode pads have a limited shelf life because the conductivity of the adhesive gel that will decrease with time.

Zoll CPR/D Padz (are.8900-0800-01)
These pads are the preferred pads for the Zoll AEDs as they have been developed for maximum  convenience. Each pad has been made from one piece, which makes accurate positioning easier. These pads have a sensor that measure the depth of the chest compressions. The AED responds to these measurements by giving extra instructions such as ‘press harder’. Better chest compressions will help to increase the chances of survival. The CPR/D pads have a 5 years shelf life. This explains the higher purchase price compared to the other Zoll electrode pads. These electrode pads are  intended for adults.

Zoll CPR Stat Padz (art.8900-0400)
The CPR Stat Padz are not made out of one piece like the CPR/D pads, but are provided with a sensor. These pads are made for the aid worker who welcomes extra instructions but not one-piece pads. These electrodes may also prove advantageous when the AED is used regularly. Their price is lower, all functionality is preserved and their shorter shelf life (about 2 years) is less important. These sets are intended for adult uses.

Stat Padz II (art. 8900-0801-01 Zoll)
Stat Padz are sold widely to people who have no interest in the CPR-feedback of the Zoll AEDs; no sensor is attached to the pads and there is no feedback. This product is made for the very CPR experienced aid worker who would not benefit much from CPR feedback. The electrodes are only connected to each other through a cable and are therefore not made out of one piece. These are the most favourably priced electrode pads and have a shelf life of approximately two years.

Zoll Pedi Padz (art. 8900-0810-01)
The Pedi Padz are intended for children up to 8 years of age or about 25 kg of body weight.

These electrodes guide the energy level of the shock downwards in order to provide optimum therapeutic benefit to smaller bodies.  It is good practice to keep paediatric pads in the vicinity of the AED when it is kept  in a place where many children are present.

Paramedic suffers heart attack while giving CPR to patient.

 It will take months before Paramedic Joseph Hardman from Detroit will recover from his last ride. While saving a heart attact patient, he suffers a serious heart attack himself on route to the Hospital.

When Heardman starting sweating and experiencing a sudden explosion-type feeling in his chest, he knew he was having a heart attack. But he kept working to save the life of the man in his care.

Hardman warned his partner, who was driving to the Detroit Medical Center, that there’d be two patients having a heart attack instead of one. “If  we hadn’t been on the route to the hospital, I don’t know if I would have survived”, he says.

 Since this magical ride, Joseph HHero EMT Suffers Heart Attack While Saving Heart Attack Patientardman is being called a hero and a lifesaver. The docters says, with a couple of months of therapy, he could go back      to work. The same goes for the man whose life was saved by Hardman.

Defibrillator call for all soccer stadia in world

13 August 2013

Bolton

EVERY football pitch around the globe should have emergency care equipment on hand to help treat any players that suffer the same condition as    former footballer Fabrice Muamba, experts have said.

The ex-Bolton Wanderers midfielder was effectively dead for more than an hour when he collapsed following a cardiac arrest during an FA Cup match  last year.

Now researchers have said officials at games around the world should adopt a universal standard of emergency medical care. In June this year, the  emergency medical bag was sent to all of the 209 member associations of Fifa.

And the guidance on sudden cardiac arrest – the leading cause of sudden death in football – outlines “fundamental measures” to prevent a player dying from the condition, the experts said.

Japan’s Asahi Kasei to buy Zoll for $2.2bn

High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. See our Ts&Cs and Copyright Policy for more detail. Email ftsales.support@ft.com to buy additional rights. http://www.ft.com/cms/s/0/f1b88c10-6c32-11e1-8c9d-00144feab49a.html#ixzz1qgiOh3kw

Chemicals group Asahi Kasei is paying $2.21bn for Zoll Medical, a US maker of defibrillators and other critical care medical equipment, in a deal aimed at speeding up the Japanese group’s diversification into healthcare.

The bid, which is the third overseas acquisition by a Japanese company in the healthcare sector within just over a year, highlights the strong appetite for cross-border mergers and acquisitions as Japanese companies seek to expand outside their stagnant home market.

High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. See our Ts&Cs and Copyright Policy for more detail. Email ftsales.support@ft.com to buy additional rights. http://www.ft.com/cms/s/0/f1b88c10-6c32-11e1-8c9d-00144feab49a.html#ixzz1qgiSiK9L

Last February, Fujifilm acquired two biopharmaceutical companies from Merck, while Terumo acquired a US medical device company this January.

Asahi Kasei’s bid, which represents a 29.6 per cent premium over Zoll’s average share price over 30 days, gives the Japanese group access to the US healthcare market, the largest in the world, as well as expertise in an area which is seeing firm demand in global markets.

Zoll is one of the world’s top three makers of defibrillators, along with Philips and Physio-Control. Defibrillators are used to save lives by giving patients an electric shock in some cases of cardiac arrest.

“In the medical devices business, the US market leads the world, not only in size and scope, but also in technological innovation, so establishing a strong infrastructure in the US is an important step for Asahi Kasei,” said Taketsugu Fujiwara, company president.

The US company, which posted an 18 per cent increase in revenues to $523.7m in the year to October 2 2011, has enjoyed a cumulative average growth rate of 16 per cent for the past decade, according to a banker close to the deal.

The two companies plan to pursue new opportunities in the high-growth markets of Asia, they said.

The Japanese market for defibrillators has become saturated with the top two suppliers – Fukuda Denshi, which supplies products made by Philips, and Nihon Kohden – controlling about 80 to 90 per cent of the market, says Katsuro Hirozumi, analyst at Daiwa Institute of Research in Tokyo.

However, Zoll also provides services related to defibrillation and critical care and its LifeVest – the world’s only wearable defibrillator – has not yet been introduced into the Japanese market.

The Japanese group said it planned to make “strategic investments to accelerate the realisation of Zoll’s mission of leading the world in resuscitation technologies”.

Asahi has targeted healthcare as a key strategic sector which will “power a new phase of growth for the group”, the company said. It has a goal to build a global healthcare business with a focus on critical care.

It aims to increase sales to Y2,000bn ($24.3bn) in 2015 from Y1,598.4bn ($19.5bn) in the year to March 2011.

Asahi Kasei also aims to increase its overseas sales from 28 per cent to 32 per cent of the total by 2015.